Physician profile
Jaddon Rogers
NPI 1134638810
$3,519.24
in general payments reported to CMS, 2019-2025
18 companies · $626 in 2025
The $626 reported for 2025 was more than what 75% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $584 · 2022: $588 · 2023: $490 · 2024: $1,230 · 2025: $626.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,247 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,247.01 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,013.05 | 2021-2025 | |
| Janssen Biotech, INC. | $521.14 | 2021-2025 | Tremfya |
| Sun Pharmaceutical Industries INC. | $397.07 | 2021-2025 | Ilumya |
| Novartis Pharmaceuticals Corporation | $386.33 | 2021-2025 | |
| Ucb, INC. | $206.99 | 2021-2025 | Bimzelx, Cimzia |
| Genzyme Corporation | $197.23 | 2022-2025 | |
| Galderma Laboratories, L.P. | $173.11 | 2021-2025 | Nemluvio, Aklief |
| Lilly USA, LLC | $164.06 | 2021-2024 | Taltz, Olumiant, Ebglyss |
| Arcutis Biotherapeutics, INC. | $86.97 | 2023-2024 | Zoryve |
| Pfizer INC. | $68.45 | 2024-2025 | |
| Leo Pharma INC. | $60.79 | 2022-2024 | Adbry |
| Regeneron Healthcare Solutions, INC. | $50.00 | 2021-2023 | Libtayo |
| Organon LLC | $48.42 | 2024-2025 | |
| Amgen INC. | $40.09 | 2024 | Otezla |
| Boehringer Ingelheim Pharmaceuticals, INC. | $36.06 | 2024 | Spevigo |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $35.70 | 2021-2024 | Cabtreo |
| Biofrontera INC. | $18.11 | 2021 | |
| Botanix Sb INC | $15.67 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jaddon Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.